Evidence map›Paper›PMID 25053279›Full record

ArticleAddiction biology2015

The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.

Yvonne E Ogbonmwan, Natale R Sciolino, Jessica L Groves-Chapman, Kimberly G Freeman, Jason P Schroeder, Gaylen L Edwards, Philip V Holmes, David Weinshenker

Abstract read
In one paragraph

Article in Addiction biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yvonne E OgbonmwanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
Natale R SciolinoNeuroscience Program, Biomedical and Health Sciences Institute, University of Georgia, Athens, GA, USA.
Jessica L Groves-ChapmanNeuroscience Program, Biomedical and Health Sciences Institute, University of Georgia, Athens, GA, USA.
Kimberly G FreemanDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Jason P SchroederDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
Gaylen L EdwardsDepartment of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.
Philip V HolmesNeuroscience Program, Biomedical and Health Sciences Institute, University of Georgia, Athens, GA, USA.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.
University of Georgia · USEmory University · US

Funding

Training Program in Neurobiology of Drug AbuseT32DA015040 · NIDA · EMORY UNIVERSITY · PI KUHAR, MICHAEL J · 2003 to 2012
$3.6M
Effects of voluntary exercise on reinstatement of cocaine seekingR01DA027535 · NIDA · EMORY UNIVERSITY · PI HOLMES, PHILIP V, WEINSHENKER, DAVID · 2010 to 2014
$1.9M
Identification of mechanisms underlying reduction of cocaine seeking by exerciseF31DA033091 · NIDA · EMORY UNIVERSITY · PI OGBONMWAN, YVONNE ENIYE · 2012 to 2014
$88k
NIDA NIH HHS DA015040NIDA NIH HHS DA027535NIDA NIH HHS DA033091NIDA NIH HHS F31 DA033091NIDA NIH HHS R01 DA027535NIDA NIH HHS T32 DA015040
6 · The paper itself

Abstract

Relapse represents one of the most significant problems in the long-term treatment of drug addiction. Cocaine blocks plasma membrane monoamine transporters and increases dopamine (DA) overflow in the brain, and DA is critical for the motivational and primary reinforcing effects of the drug as well as cocaine-primed reinstatement of cocaine seeking in rats, a model of relapse. Thus, modulators of the DA system may be effective for the treatment of cocaine dependence. The endogenous neuropeptide galanin inhibits DA transmission, and both galanin and the synthetic galanin receptor agonist, galnon, interfere with some rewarding properties of cocaine. The purpose of this study was to further assess the effects of galnon on cocaine-induced behaviors and neurochemistry in rats. We found that galnon attenuated cocaine-induced motor activity, reinstatement and DA overflow in the frontal cortex at a dose that did not reduce baseline motor activity, stable self-administration of cocaine, baseline extracellular DA levels or cocaine-induced DA overflow in the nucleus accumbens (NAc). Similar to cocaine, galnon had no effect on stable food self-administration but reduced food-primed reinstatement. These results indicate that galnon can diminish cocaine-induced hyperactivity and relapse-like behavior, possibly in part by modulating DA transmission in the frontal cortex.

Indexed as

AnimalsCocaineCocaine-Related DisordersConditioning, OperantCoumarinsDopamineDopamine Uptake InhibitorsDrug-Seeking BehaviorEatingExtinction, PsychologicalFrontal LobeGalaninMaleMicrodialysisMotor ActivityNucleus Accumbens7-((9-fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino-4-methylcoumarinCocaineCoumarinsDopamineDopamine Uptake InhibitorsGalaninCocainecortexdopaminegalaningalnonreinstatement

Identifiers

PMID25053279
PMCPMC4305031
OpenAlexW1692459684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.